Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Terrorism and cancer

G A Curt

    The Oncologist
    |October 25, 2001
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemia.

    Investigational new drugs·2011
    Same author

    [Fatigue syndrome caused by malignant tumor. An increasing priority in patient care].

    Recenti progressi in medicina·2001
    Same author

    Fatigue in cancer.

    BMJ (Clinical research ed.)·2001
    Same author

    Impact of fatigue on quality of life in oncology patients.

    Seminars in hematology·2000
    Same author

    Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition.

    The oncologist·2000
    Same author

    The impact of fatigue on patients with cancer: overview of FATIGUE 1 and 2.

    The oncologist·2000
    Same journal

    Prevalence, treatment and survival of Malignant Peripheral Nerve Sheath Tumor in the Danish neurofibromatosis type 1 population.

    The oncologist·2026
    Same journal

    Molecular Tumor Board-Guided Osimertinib Therapy in EGFR L858R/Q701L-Mutant Lung Adenocarcinoma Supported by Functional Validation.

    The oncologist·2026
    Same journal

    Phase 2 Dose Expansion Trial of OBI-3424, a DNA-Alkylating Prodrug, in Patients with Advanced Solid Tumors Expressing AKR1C3.

    The oncologist·2026
    Same journal

    Divergent Biology and Outcomes of Somatic Transformations in Germ Cell Tumors.

    The oncologist·2026
    Same journal

    Modernizing Disease Assessment in Prostate Cancer Trials: The Prostate Cancer Working Group 4 Framework.

    The oncologist·2026
    Same journal

    Use of liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in neoadjuvant pancreatic adenocarcinoma: NEO-Nal-IRI trial.

    The oncologist·2026
    See all related articles